Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 142


An intervention to reduce the number of convenience stores selling tobacco: feasibility study.

Paynter J, Glover M, Bullen C, Sonia D.

Tob Control. 2015 Apr 14. pii: tobaccocontrol-2014-052045. doi: 10.1136/tobaccocontrol-2014-052045. [Epub ahead of print]


Ex vivo analysis identifies effective HIV-1 latency-reversing drug combinations.

Laird GM, Bullen CK, Rosenbloom DI, Martin AR, Hill AL, Durand CM, Siliciano JD, Siliciano RF.

J Clin Invest. 2015 May;125(5):1901-12. doi: 10.1172/JCI80142. Epub 2015 Mar 30.


E-cigarettes versus NRT for smoking reduction or cessation in people with mental illness: secondary analysis of data from the ASCEND trial.

O'Brien B, Knight-West O, Walker N, Parag V, Bullen C.

Tob Induc Dis. 2015 Mar 24;13(1):5. doi: 10.1186/s12971-015-0030-2. eCollection 2015.


Guidance to employers on integrating e-cigarettes/electronic nicotine delivery systems into tobacco worksite policy.

Whitsel LP, Benowitz N, Bhatnagar A, Bullen C, Goldstein F, Matthias-Gray L, Grossmeier J, Harris J, Isaac F, Loeppke R, Manley M, Moseley K, Niemiec T, O╩╝Brien V, Palma-Davis L, Pronk N, Pshock J, Stave GM, Terry P.

J Occup Environ Med. 2015 Mar;57(3):334-43. doi: 10.1097/JOM.0000000000000420.


Cytisine versus nicotine for smoking cessation.

Walker N, Howe C, Glover M, McRobbie H, Barnes J, Nosa V, Parag V, Bassett B, Bullen C.

N Engl J Med. 2014 Dec 18;371(25):2353-62. doi: 10.1056/NEJMoa1407764.


Electronic cigarettes for smoking cessation and reduction.

McRobbie H, Bullen C, Hartmann-Boyce J, Hajek P.

Cochrane Database Syst Rev. 2014;12:CD010216. doi: 10.1002/14651858.CD010216.pub2. Epub 2014 Dec 17. Review.


Abrupt nicotine reduction as an endgame policy: a randomised trial.

Walker N, Fraser T, Howe C, Laugesen M, Truman P, Parag V, Glover M, Bullen C.

Tob Control. 2014 Nov 14. pii: tobaccocontrol-2014-051801. doi: 10.1136/tobaccocontrol-2014-051801. [Epub ahead of print]


A primary CD4(+) T cell model of HIV-1 latency established after activation through the T cell receptor and subsequent return to quiescence.

Kim M, Hosmane NN, Bullen CK, Capoferri A, Yang HC, Siliciano JD, Siliciano RF.

Nat Protoc. 2014 Dec;9(12):2755-70. doi: 10.1038/nprot.2014.188. Epub 2014 Nov 6.


Electronic cigarettes for smoking cessation.

Bullen C.

Curr Cardiol Rep. 2014 Nov;16(11):538. doi: 10.1007/s11886-014-0538-8. Review.


Effects of exercise on the desire to smoke and physiological responses to temporary smoking abstinence: a crossover trial.

Roberts V, Gant N, Sollers JJ 3rd, Bullen C, Jiang Y, Maddison R.

Psychopharmacology (Berl). 2015 Mar;232(6):1071-81. doi: 10.1007/s00213-014-3742-8. Epub 2014 Sep 30.


Prevalence and risk factors for tobacco smoking among pre-adolescent Pacific children in New Zealand.

Nosa V, Gentles D, Glover M, Scragg R, McCool J, Bullen C.

J Prim Health Care. 2014 Sep 1;6(3):181-8.


Electronic cigarettes: a policy statement from the American Heart Association.

Bhatnagar A, Whitsel LP, Ribisl KM, Bullen C, Chaloupka F, Piano MR, Robertson RM, McAuley T, Goff D, Benowitz N; American Heart Association Advocacy Coordinating Committee, Council on Cardiovascular and Stroke Nursing, Council on Clinical Cardiology, and Council on Quality of Care and Outcomes Research.

Circulation. 2014 Oct 14;130(16):1418-36. doi: 10.1161/CIR.0000000000000107. Epub 2014 Aug 24. No abstract available.


Effect of a family-centered, secondhand smoke intervention to reduce respiratory illness in indigenous infants in Australia and New Zealand: a randomized controlled trial.

Walker N, Johnston V, Glover M, Bullen C, Trenholme A, Chang A, Morris P, Segan C, Brown N, Fenton D, Hawthorne E, Borland R, Parag V, Von Blaramberg T, Westphal D, Thomas D.

Nicotine Tob Res. 2015 Jan;17(1):48-57. doi: 10.1093/ntr/ntu128. Epub 2014 Aug 25.


Operational research in the South Pacific.

Bullen C, van Griensven J.

Public Health Action. 2014 Jun 21;4(Suppl 1):S1. doi: 10.5588/pha.14.0034. No abstract available.


Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care.

Selak V, Elley CR, Bullen C, Crengle S, Wadham A, Rafter N, Parag V, Harwood M, Doughty RN, Arroll B, Milne RJ, Bramley D, Bryant L, Jackson R, Rodgers A.

BMJ. 2014 May 27;348:g3318. doi: 10.1136/bmj.g3318.


A systematic review of barriers and facilitators to participation in randomized controlled trials by Indigenous people from New Zealand, Australia, Canada and the United States.

Glover M, Kira A, Johnston V, Walker N, Thomas D, Chang AB, Bullen C, Segan CJ, Brown N.

Glob Health Promot. 2015 Mar;22(1):21-31. doi: 10.1177/1757975914528961. Epub 2014 May 19.


Context on use is needed before public health recommendations are made about e-cigarettes.

Knight-West O, O'Brien B, Walker N, Bullen C.

Am J Prev Med. 2014 Jun;46(6):e57-8. doi: 10.1016/j.amepre.2014.03.008. No abstract available.


New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo.

Bullen CK, Laird GM, Durand CM, Siliciano JD, Siliciano RF.

Nat Med. 2014 Apr;20(4):425-9. doi: 10.1038/nm.3489. Epub 2014 Mar 23.


Protecting children from taking up smoking: parents' views on what would help.

Marck K, Glover M, Kira A, McCool J, Scragg R, Nosa V, Bullen C.

Health Promot J Austr. 2014 Apr;25(1):59-64. doi: 10.1071/HE13029.


Evidence, not conjecture, should guide clinical practice and policies on e-cigarettes.

Bullen C, Knight-West O, O'Brien B, Walker N.

BMJ. 2014 Mar 10;348:g2008. doi: 10.1136/bmj.g2008. No abstract available.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk